"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection
CCRPWAR
1 other identifier
interventional
346
0 countries
N/A
Brief Summary
How to reduce the complications of perineal wound after abdominoperineal resection (APR) has always been a hot topic in the medical field.To reduce the complications of perineal wound and the primary healing of perineal wound must meet the two principles of "unobstructed drainage" and " reduced tension closure".This concept is similar to the concepts of closure of enterostomy in rectal cancer patients. It was reported that use of cross-stitch closure can significantly reduce complications of closure of enterostomy. So the investigator ever used the "cross" closure to reconstruct the perineal wound of APR, which was really decrease the complications of perineal wound. However, more clinical trails was needed to confirm the conclusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2018
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2018
CompletedFirst Posted
Study publicly available on registry
November 6, 2018
CompletedStudy Start
First participant enrolled
November 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2020
CompletedNovember 9, 2018
October 1, 2018
2 years
October 26, 2018
November 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complication rate of perineal wound
the complications of perineal wound are include wound infection, wound effusion, wound liquefaction, wound dehiscence, seroma or hematoma ,delayed wound healing, presacral or perineal abscess, perineal or pelvic floor hernia
Within 30 days after operation
Secondary Outcomes (11)
Primary wound healing rate
Within 30 days after operation
CTCAE grade for complications of perineal wound
Within 30 days after surgery
The incidence of each complication of perineal wound
Within 30 days after surgery
The rate of reoperation
Within 30 days after surgery
The volumes of presacral drainage
Within 3, 5, 7 days after surgery
- +6 more secondary outcomes
Study Arms (2)
Traditional Closure
ACTIVE COMPARATORPatients receive primary closure discontinuously for reconstruction of APR perineal wound
"Cross" Closure
EXPERIMENTALPatients receive "cross" closure for reconstruction of APR perineal wound
Interventions
Primary closure discontinuously the perineal wound of APR
Two triangles of skin in the horizontal direction are excised to enlarge the skin incision, and the tumor resected. Then circumferential subcuticular suture of wound, and with tightening of the circumferential suture, the wound resembles a cross.
Eligibility Criteria
You may qualify if:
- Age: 18-75 years old;
- ECOG performance status: 0-2;
- Histologically confirmed rectal cancer or anal canal cancer;
- Completely resected the primary tumor;
- No evidence of distant metastasis;
- Tolerable general anesthesia;
- Total radiation dose of 45-50 Gy needed if the patient needs to receive routine segmental radiotherapy;
- Provision of written informed consent.
You may not qualify if:
- Emergency surgery required when the patients combined with acute ileus, perforation and hemorrhage;
- Extralevator abdominoperineal resection needed;
- American Society of Anesthesiologists (ASA) IV or V;
- Combined with other tumors;
- Severe mental illness;
- (7)Serious cardiovascular disease, uncontrolled infections, or other serious uncontrolled concomitant disease; (8)Expectation of lateral lymph node dissection preoperatively
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sixth Affiliated Hospital, Sun Yat-sen Universitylead
- First Affiliated Hospital, Sun Yat-Sen Universitycollaborator
- First Affiliated Hospital of Jinan Universitycollaborator
- The First Affiliated Hospital of Guangzhou Medical Universitycollaborator
- Second Affiliated Hospital of Guangzhou Medical Universitycollaborator
- Southern Medical University, Chinacollaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicinecollaborator
- Guangzhou First People's Hospitalcollaborator
- Affiliated Hospital of Guangdong Medical Universitycollaborator
- Cancer Institute and Hospital, Chinese Academy of Medical Sciencescollaborator
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicinecollaborator
- Meizhou People's Hospitalcollaborator
- Jieyang People's Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lei Wang, MD, PhD
Sixth Affiliated Hospital, Sun Yat-sen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2018
First Posted
November 6, 2018
Study Start
November 20, 2018
Primary Completion
November 20, 2020
Study Completion
December 20, 2020
Last Updated
November 9, 2018
Record last verified: 2018-10